JEFFREY BEAIRD: Open Payments
NPI 1821415621 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 31 payments from 18 companies in 2025. Trend: 2023 $161 · 2024 $457 · 2025 $866
Food & beverage: $847Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $154 |
| Vantive US Healthcare LLC | 1 | $105 |
| Alnylam Pharmaceuticals Inc. | 3 | $99 |
| AKEBIA THERAPEUTICS INC | 3 | $73 |
| Ardelyx, Inc. | 4 | $69 |
| Aurinia Pharma U.S., Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: LOKELMA, GIVLAARI, Vafseo, IBSRELA, LUPKYNIS, JARDIANCE, Fabhalta, TARPEYO.
Industry payments across AZ — which companies pay providers there.
